Daily non-political popular news in brief.

Could statins be a new option for hepatitis C patients?

Research presented today at Digestive Disease Week® 2007 (DDW®) demonstrates the potential of statins, important cholesterol management therapies, for improving the management of hepatitis C — a disease that affects nearly four million Americans.

Read more »

Keywords: statins, option, hepatitis, patients, statin, hepatiti, patient

« Previous | Next »

Similar news on "Could statins be a new option for hepatitis C patients?":

1. Scientists identify gene responsible for statin-induced muscle pain
   11-27-2007 · EurekAlert!
   Statins, the popular class of drugs used to lower cholesterol, are among the most commonly prescribed medications in developed countries. But for some patients, accompanying side effects of muscle weakness and pain become chronic problems and, in rare cases, can escalate to debilitating and even life-threatening damage. Now a study led by investigators at Beth Israel Deaconess Medical Center, helps explain the source of these problems.
   Similar news · Read more »
   
2. 24-week course of interferon-alpha therapy prolongs survival in patients hepatitis C virus
   11-02-2007 · EurekAlert!
   A group at Hiroshima University Hospital performed a matched historical controlled study on whether a 24-week course of interferon-alpha therapy, after curative treatment for primary hepatocellular carcinoma associated with hepatitis C virus, could influence tumor recurrence, patient survival, and liver function. Patients with sustained virological responses had reduced recurrence, prolonged survival and a preserved liver function. The group also determined that viral eradication was the most important factor in such patients.
   Similar news · Read more »
   
3. Statin use associated with lower risk of death and hospitalization for patients with heart failure
   10-31-2006 · EurekAlert!
   Patients with heart failure who used statins for the first time had a reduced risk of death of nearly 25 percent, compared to non-users, and also a lower risk for hospitalization, according to a study in the Nov. 1 issue of JAMA.
   Similar news · Read more »
   
4. Rare case of dental patient-to-patient hepatitis B virus transmission recorded
   04-03-2007 · EurekAlert!
   Researchers have documented a case of hepatitis B virus (HBV) transmission between two patients at a dentist's office in the United States. While this kind of infection is exceedingly rare, universal vaccination against the virus would likely have prevented both cases, according to the authors of the case report and an accompanying commentary. Both appear in the May 1 issue of the Journal of Infectious Diseases, now available online.
   Similar news · Read more »
   
5. Hepatitis B patients' understanding of infection and treatment deficient
   05-24-2007 · EurekAlert!
   Many patients with chronic hepatitis B are deficient in their understanding of the lifelong disease and often do not comply with the drug regimens necessary to control it, according to a new UCLA survey that suggests improved patient involvement in disease management decisions could be the key to fixing this problem.
   Similar news · Read more »
   
6. Hepatitis B drug can compromise HIV treatment
   06-20-2007 · EurekAlert!
   Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. In findings published in the New England Journal of Medicine, researchers reported that a patient infected with both hepatitis B and HIV who was treated with entecavir developed a mutant strain of HIV that is resistant to the antiviral drugs lamivudine and emtricitabine.
   Similar news · Read more »
   
7. New biologic treatment for tennis elbow may replace surgery for chronic sufferers
   10-23-2006 · EurekAlert!
   "Tennis elbow" isn't restricted to tennis players; it's a common, chronic problem for people whose activities require strong gripping or repetitive wrist motions. A novel biologic treatment of injecting the patient's own platelets into the affected tendon proves successful and gives patients another treatment option before undergoing surgery. The procedure has wide application for healing of other medical conditions, say researchers from Stanford University.
   Similar news · Read more »
   
8. New study to test Statin-Parkinson's link
   01-15-2007 · EurekAlert!
   Results of a recent study linking low LDL cholesterol to Parkinson's provide the strongest evidence to date that it could be real, because statins work by reducing LDL cholesterol. The study by researchers at University of North Carolina showed that patients with low levels of LDL cholesterol are more than three and a half times more likely to develop Parkinson's disease than those with higher LDL levels.
   Similar news · Read more »
   
9. Other highlights in the December 20 JNCI
   12-19-2006 · EurekAlert!
   Also in the December 20 issue of JNCI -- A report on breast cancer stem cells and radiation; research connecting statin use and advanced prostate cancer; a study of asthma medication and pancreatic cancer cell growth; and a model that predicts the risks of radiation therapy for leukemia patients.
   Similar news · Read more »
   
10. Protecting HIV patients from Hepatitis B virus
    07-17-2007 · EurekAlert!
    As it is not quite clear how HIV patients that don’t respond to the HBV vaccine should be managed, new research from the University of Alberta has evaluated the immune response of HBV vaccine given intradermally (into the skin) in HIV-infected individuals who failed to respond to two cycles of HBV vaccine given intramuscularly (into the muscle).
    Similar news · Read more »